















As research into psychedelic-assisted therapy for mental and behavioral health conditions advances, stakeholders are navigating a complex path towards regulatory approval, funding models, and ethical considerations. Collaborative efforts can drive innovation, expand access, and shape the future of this transformative approach to care especially for populations like our Veterans with the greatest need for these highly effective treatments.